WDR45L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.910000E-01
Normal-vs-Stage2
5.278800E-01
Normal-vs-Stage3
8.626800E-01
Normal-vs-Stage4
6.046200E-01
Stage1-vs-Stage2
8.275000E-01
Stage1-vs-Stage3
4.567400E-01
Stage1-vs-Stage4
7.663000E-01
Stage2-vs-Stage3
3.599200E-01
Stage2-vs-Stage4
6.848000E-01
Stage3-vs-Stage4
6.280200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.431000E-01
Normal-vs-AfricanAmerican
4.322400E-01
Normal-vs-Asian
2.135200E-01
Caucasian-vs-AfricanAmerican
9.610600E-01
Caucasian-vs-Asian
5.887000E-01
AfricanAmerican-vs-Asian
7.379000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.809600E-01
Normal-vs-Female
1.110480E-02
Male-vs-Female
2.046000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.503200E-01
Normal-vs-Age(41-60Yrs)
1.016410E-03
Normal-vs-Age(61-80Yrs)
6.838200E-01
Normal-vs-Age(81-100Yrs)
5.496600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.355600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.470600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.464600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.996000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.351900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.922200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.807430E-01
Normal-vs-Daily Drinker
1.493160E-01
Normal-vs-Weekly Drinker
8.960600E-01
Normal-vs-Occasional Drinker
2.421400E-01
Normal-vs-Social Drinker
2.786400E-01
Non Drinker-vs-Daily Drinker
9.565600E-01
Non Drinker-vs-Weekly Drinker
2.568200E-01
Non Drinker-vs-Occasional Drinker
6.873200E-01
Non Drinker-vs-Social Drinker
8.136000E-01
Daily Drinker-vs-Weekly Drinker
2.306800E-01
Daily Drinker-vs-Occasional Drinker
6.191800E-01
Daily Drinker-vs-Social Drinker
7.611000E-01
Weekly Drinker-vs-Occasional Drinker
4.534100E-02
Weekly Drinker-vs-Social Drinker
7.430100E-02
Occasional Drinker-vs-Social Drinker
8.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.284590E-01
Normal-vs-Grade 2
4.462100E-02
Normal-vs-Grade 3
1.031820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.386200E-01
Grade 1-vs-Grade 3
8.525200E-01
Grade 1-vs-Grade 4
1.284590E-01
Grade 2-vs-Grade 3
3.097000E-01
Grade 2-vs-Grade 4
4.462100E-02
Grade 3-vs-Grade 4
1.031820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.826600E-01
Normal-vs-NonDiabetic
5.917100E-03
Diabetic-vs-NonDiabetic
1.280780E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.687500E-02
Normal-vs-NoPancreatitis
6.086600E-01
Pancreatitis-vs-NoPancreatitis
1.663570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.003000E-01
Normal-vs-N1
2.225600E-02
N0-vs-N1
4.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.903700E-03
Normal-vs-TP53-NonMutant
2.227800E-02
TP53-Mutant-vs-TP53-NonMutant
5.878200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
